NCT06854835

Brief Summary

TBI, as a potential risk factor, causes a 1.5 times higher risk of neurodegenerative disease to up to 30-70% of TBI patients with neurological symptoms. Brain trauma is an important global medical, public health and social problem. Early diagnosis and effective treatment can effectively reduce the disability rate of patients and the incidence of neurological sequelae, and has increasingly become the focus of the international scientific research community. Exploring blood-based biomarkers has potential clinical value, which can greatly help clinicians to evaluate patients' conditions and develop reasonable plans, and then improve the clinical management and treatment of patients with craniocerebral trauma. Further research work is needed to be done to identify the most effective and efficient biomarker or combination marker strategies for integration into clinical treatment.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
15mo left

Started Mar 2025

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Mar 2025Jul 2027

First Submitted

Initial submission to the registry

January 6, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 3, 2025

Completed
12 days until next milestone

Study Start

First participant enrolled

March 15, 2025

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2027

Last Updated

March 3, 2025

Status Verified

January 1, 2025

Enrollment Period

2.4 years

First QC Date

January 6, 2025

Last Update Submit

February 25, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Full Outline of Unresponsiveness, FOUR

    The FOUR is an questionnaire which has four main assessments: eye opening, exercise, brain stem reflex, and respiratory function. Each item has a full score of 4 and a total score of 16. Brainstem reflex and respiratory function of FOUR are more sensitive than the GCS language score for predicting mortality risk in ICU patients. The total score was 0 to 16, with lower scores indicating a greater probability of death and disability.

    On admission (within 24 hours), 3 days of admission and at discharge (up to 24 weeks)

  • Glasgow Outcome Scale-Extended, GOS-E

    GOS-E is a clinical assessment tool for assessing function and quality of life in patients with head trauma. This is an expanded version of the Glasgow Rating Scale, designed to provide a more comprehensive assessment to better understand the patient's recovery. The GOS-E scores were divided into the following categories: 1= death, 2= vegetative state, 3= severe disability, 4= moderate to severe disability, 5= moderate disability, 6= mild disability, 7= good recovery, and 8= complete recovery

    On admission (within 24 hours), 3 days of admission and at discharge (up to 24 weeks)

  • Head MRI

    The MRI scan sequence includes the following: 1. 3-pl (positioning image requires preservation of the whole brain, including overhead scalp to all cerebellum) (check the parameters before scanning) 2. T2-FLAIR (predict brain conditions, if abnormal lesions, stop scanning immediately) 3. ESWAN 4. T1-weighted 3D-MPRAGE 5. DTI 6. Resting State (BOLD) (positioning line is parallel to AC-PC line) 7. ASL 8. Axial-T1

    On admission (within 24 hours), 3 days of admission and at discharge (up to 24 weeks)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Eighty voluntary TBI patients were recruited prospectively in strict accordance with the inclusion and exclusion criteria. Patients with TBI were divided into three groups: mild to moderate and severe according to GCS scores. At the same time, 80 limb fracture control group matched by gender, age and education were recruited.

You may qualify if:

  • Age: 18-65 years old
  • Time of injury: patients with acute traumatic brain injury within 24h
  • Glasgow Coma Scale (Glasgow Coma Scale, GCS) score: 13 to 15 for patients with mild traumatic brain injury, 9 to 12 for moderate traumatic brain injury, and 3 to 8 for patients with severe traumatic brain injury
  • No other system damage has occurred
  • Admitted to hospital for the first diagnosis after the injury

You may not qualify if:

  • With a history of neurological or psychiatric disorders
  • Traumatic brain injury occurred before the injury
  • History of alcohol or substance abuse
  • Mild brain trauma is a complication of other injuries (systemic trauma, facial trauma, or spinal cord trauma) or other causes (psychological trauma, language impairment)
  • Patients without visits, and incomplete data during treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Brain Injuries, Traumatic

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 6, 2025

First Posted

March 3, 2025

Study Start

March 15, 2025

Primary Completion (Estimated)

July 31, 2027

Study Completion (Estimated)

July 31, 2027

Last Updated

March 3, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share